Pricing

Log inSign up

Thryv Therapeutics

0 followers

‌

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated wit... Read more

Industries

Biotechnology, Therapeutics

Employees

1-10

Links

Org chart

Paul F. Truex
Chairman & CEO

Paul F. Truex

Collapse
Debra Odink
President & Chief Development Officer
Philip Sager
Chief Medical Officer
Aidan McNeil
Associate General Counsel & VP, Administration
Eric Campeau
VP, Translational Research
Curtis Mcgrath
Associate Director, Finance
Daphne Doucet
Manager, Corporate Communications

Board & advisors

Robert Booth
Director
Shi Yin Foo
Director
Daniel Hétu
Director
Melissa Koomey
Director
Jean-François Pariseau
Director
Scott Weiner
Director
Saumya Das
Board Observer
Frédéric Lemaître Auger
Board Observer
Marc-Olivier Sirard
Board Observer
Michael J Ackerman
Scientific Advisor
Stanley Nattel
Scientific Advisor
Anthony Rosenzweig
Scientific Advisor
Dinesh Srinivasan
Scientific Advisor
Arthur A.m. Wilde
Scientific Advisor

Teams

+11

Research and Development

14 members

+4

Corporate Governance

7 members

+3

Leadership Team

6 members

Offices

This company has no offices yet

Similar companies

Antag Therapeutics

1 follower

Amgen

235 followers

Pierre Fabre

9 followers

Thermo Fisher Scientific

180 followers

Genentech

163 followers

Gilead Sciences

136 followers

Agilent Technologies

72 followers

Lonza

37 followers

BioMarin Pharmaceutical

37 followers

Verily Life Sciences

38 followers

Myriad Genetics

37 followers

Explore companies